Clinical trial
Management of Atrial Fibrillation Suppression in AF-HF COmorbidity Therapy
NCT00187252 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Management of Atrial Fibrillation Suppression in AF-HF COmorbidity Therapy
- Lead sponsor
- Abbott Medical Devices
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 30, 2003
- Completion date
- June 30, 2008
- Enrollment
- 380 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.